Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1708044 | 0.99 | L3MBTL1 (0.33) | L3MBTL1ADORA2B | |
| SCHEMBL1708628 | 0.91 | MAPT (0.32) | ADORA2B | |
| SCHEMBL1708395 | 0.91 | MAPT (0.32) | ADORA2B | |
| SCHEMBL1708287 | 0.91 | MAPT (0.32) | ADORA2B | |
| SCHEMBL1708091 | 0.90 | ADORA2B (0.31) | ADORA2B | |
| SCHEMBL1708661 | 0.89 | MAPT (0.33) | L3MBTL1ADORA2B | |
| SCHEMBL1708673 | 0.89 | MAPT (0.33) | L3MBTL1ADORA2B | |
| SCHEMBL1707971 | 0.87 | MAPT (0.34) | ADORA2B | |
| SCHEMBL1708269 | 0.87 | MAPT (0.34) | ADORA2B | |
| SCHEMBL1708163 | 0.87 | MAPT (0.34) | ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2440541-A1 | NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2012-04-18 | — | — | EP | disclosed |
| WO-2010143733-A1 | NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-12-16 | — | — | WO | disclosed |